SCHEMBL15428883

SCHEMBL15428883

NC(=O)NC(=O)[CH]C1CCCCC1

nearest known ligand 0.39

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 7/20 0.39
NPC1 O15118 3/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
HTT P42858 1/20 0.33
GAA P10253 1/20 0.33
RAB9A P51151 2/20 0.32
MAPT P10636 2/20 0.32
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
CYP3A4 P08684 1/20 0.32
EPHX2 P34913 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
GRIK1 P39086 1/20 0.32
CACNA1B Q00975 1/20 0.32
APBA1 Q02410 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3418328 0.80 EPHX1 (0.36) EPHX1NPC1SMN1; SMN2RAB9AMAPT
SCHEMBL15428845 0.80 MAPT (0.30) MAPTCACNA1BAPBA1
SCHEMBL6043876 0.75 EPHX1 (0.41) EPHX1NPC1SMN1; SMN2RAB9AMAPT
SCHEMBL176778 0.75 EPHX1 (0.41) EPHX1NPC1SMN1; SMN2RAB9AMAPT
SCHEMBL6043676 0.74 EPHX1 (0.36) EPHX1NPC1SMN1; SMN2HTTGAA
SCHEMBL27739172 0.74 EPHX1 (0.36) EPHX1NPC1SMN1; SMN2HTTGAA
SCHEMBL2836151 0.72
SCHEMBL6265799 0.71 ALOX5 (0.39) EPHX1MAPTMEN1KMT2ACACNA1B
Cyclopentane SCHEMBL22729196 0.68 CRBN (0.50) EPHX1NPC1SMN1; SMN2RAB9AMAPT
Cyclohexane SCHEMBL1882975 0.68 CRBN (0.50) EPHX1NPC1SMN1; SMN2RAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2935211-A1 INDOLE CARBOXAMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS Actelion Pharmaceuticals Ltd. (CH) 2015-10-28 EP claimed
WO-2014097140-A1 INDOLE CARBOXAMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2014-06-26 WO claimed
EP-2935211-A1 INDOLE CARBOXAMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS Actelion Pharmaceuticals Ltd. (CH) 2015-10-28 EP disclosed
WO-2014097140-A1 INDOLE CARBOXAMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2014-06-26 WO disclosed
US-8637550-B2 Heteroaryl diamide compounds useful as MMP-13 inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-01-28 US disclosed